Century Therapeutics IPSC
NASDAQ IPSC
$2.11 +0.02 (+0.96%)
At close: Sep 4, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Price to Earnings (2021 - 2026)

Analysis

Century Therapeutics (IPSC) Price to Earnings (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Century Therapeutics 440.37 Mn 180.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.80
Mar 31, 2026 -18.79
Dec 31, 2025 -4.54
Sep 30, 2025 -1.26
Jun 30, 2025 -1.49
Mar 31, 2025 0.54
Dec 31, 2024 -10.66
Sep 30, 2024 -4.63
Jun 30, 2024 -6.91
Mar 31, 2024 -8.99
Dec 31, 2023 -5.08
Sep 30, 2023 -3.64
Jun 30, 2023 -5.63
Mar 31, 2023 -6.56
Dec 31, 2022 -9.47
Sep 30, 2022 -18.71
Jun 30, 2022 -15.61
Mar 31, 2022 -19.33
Dec 31, 2021 -18.25
Sep 30, 2021 -52.86